A set of gene variants originating in Sub-Saharan West Africa may help explain why black women have worse breast cancer outcomes than white women, say researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.
Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.
Neuroscientist Valerie Reyna has been named a member of the National Academy of Medicine for distinguished contributions to medicine and health. Her work integrates brain and behavioral research.
On March 8, Dr. Laurie Glimcher, dean of Weill Cornell Medicine, announced the launch of the President Elizabeth Garrett Fund for Colon Cancer Research.
From studying labor law to understanding obesity, about undergraduate scholars shared their results at the Hunter R. Rawlings III Research Scholars Senior Expo and at CURBx, April 19.